572 related articles for article (PubMed ID: 12198137)
1. Bcl-XL protects BimEL-induced Bax conformational change and cytochrome C release independent of interacting with Bax or BimEL.
Yamaguchi H; Wang HG
J Biol Chem; 2002 Nov; 277(44):41604-12. PubMed ID: 12198137
[TBL] [Abstract][Full Text] [Related]
2. Direct addition of BimL to mitochondria does not lead to cytochrome c release.
Terradillos O; Montessuit S; Huang DC; Martinou JC
FEBS Lett; 2002 Jul; 522(1-3):29-34. PubMed ID: 12095614
[TBL] [Abstract][Full Text] [Related]
3. Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins.
Moreau C; Cartron PF; Hunt A; Meflah K; Green DR; Evan G; Vallette FM; Juin P
J Biol Chem; 2003 May; 278(21):19426-35. PubMed ID: 12642586
[TBL] [Abstract][Full Text] [Related]
4. Bak BH3 peptides antagonize Bcl-xL function and induce apoptosis through cytochrome c-independent activation of caspases.
Holinger EP; Chittenden T; Lutz RJ
J Biol Chem; 1999 May; 274(19):13298-304. PubMed ID: 10224090
[TBL] [Abstract][Full Text] [Related]
5. Cytoprotective peptide humanin binds and inhibits proapoptotic Bcl-2/Bax family protein BimEL.
Luciano F; Zhai D; Zhu X; Bailly-Maitre B; Ricci JE; Satterthwait AC; Reed JC
J Biol Chem; 2005 Apr; 280(16):15825-35. PubMed ID: 15661735
[TBL] [Abstract][Full Text] [Related]
6. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis.
Desagher S; Osen-Sand A; Nichols A; Eskes R; Montessuit S; Lauper S; Maundrell K; Antonsson B; Martinou JC
J Cell Biol; 1999 Mar; 144(5):891-901. PubMed ID: 10085289
[TBL] [Abstract][Full Text] [Related]
7. Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death.
Shangary S; Johnson DE
Biochemistry; 2002 Jul; 41(30):9485-95. PubMed ID: 12135371
[TBL] [Abstract][Full Text] [Related]
8. BH3 domains other than Bim and Bid can directly activate Bax/Bak.
Du H; Wolf J; Schafer B; Moldoveanu T; Chipuk JE; Kuwana T
J Biol Chem; 2011 Jan; 286(1):491-501. PubMed ID: 21041309
[TBL] [Abstract][Full Text] [Related]
9. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK
Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926
[TBL] [Abstract][Full Text] [Related]
10. Increase in the ratio of mitochondrial Bax/Bcl-XL induces Bax activation in human leukemic K562 cell line.
Liu FT; Goff LK; Hao JH; Newland AC; Jia L
Apoptosis; 2004 May; 9(3):377-84. PubMed ID: 15258470
[TBL] [Abstract][Full Text] [Related]
11. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis.
Cheng EH; Wei MC; Weiler S; Flavell RA; Mak TW; Lindsten T; Korsmeyer SJ
Mol Cell; 2001 Sep; 8(3):705-11. PubMed ID: 11583631
[TBL] [Abstract][Full Text] [Related]
12. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.
Letai A; Bassik MC; Walensky LD; Sorcinelli MD; Weiler S; Korsmeyer SJ
Cancer Cell; 2002 Sep; 2(3):183-92. PubMed ID: 12242151
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit is collaboration with pro-apoptotic Bak or Bax.
Werner AB; de Vries E; Tait SW; Bontjer I; Borst J
J Biol Chem; 2002 Jun; 277(25):22781-8. PubMed ID: 11929871
[TBL] [Abstract][Full Text] [Related]
14. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly.
Kuwana T; Bouchier-Hayes L; Chipuk JE; Bonzon C; Sullivan BA; Green DR; Newmeyer DD
Mol Cell; 2005 Feb; 17(4):525-35. PubMed ID: 15721256
[TBL] [Abstract][Full Text] [Related]
15. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4.
Huang DC; Adams JM; Cory S
EMBO J; 1998 Feb; 17(4):1029-39. PubMed ID: 9463381
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis.
Marani M; Tenev T; Hancock D; Downward J; Lemoine NR
Mol Cell Biol; 2002 Jun; 22(11):3577-89. PubMed ID: 11997495
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Bax-induced cytochrome c release from neural cell and brain mitochondria by dibucaine and propranolol.
Polster BM; Basañez G; Young M; Suzuki M; Fiskum G
J Neurosci; 2003 Apr; 23(7):2735-43. PubMed ID: 12684459
[TBL] [Abstract][Full Text] [Related]
18. Sequence and helicity requirements for the proapoptotic activity of Bax BH3 peptides.
Shangary S; Oliver CL; Tillman TS; Cascio M; Johnson DE
Mol Cancer Ther; 2004 Nov; 3(11):1343-54. PubMed ID: 15542773
[TBL] [Abstract][Full Text] [Related]
19. BH3-only proteins target BCL-xL/MCL-1, not BAX/BAK, to initiate apoptosis.
Huang K; O'Neill KL; Li J; Zhou W; Han N; Pang X; Wu W; Struble L; Borgstahl G; Liu Z; Zhang L; Luo X
Cell Res; 2019 Nov; 29(11):942-952. PubMed ID: 31551537
[TBL] [Abstract][Full Text] [Related]
20. BimS-induced apoptosis requires mitochondrial localization but not interaction with anti-apoptotic Bcl-2 proteins.
Weber A; Paschen SA; Heger K; Wilfling F; Frankenberg T; Bauerschmitt H; Seiffert BM; Kirschnek S; Wagner H; Häcker G
J Cell Biol; 2007 May; 177(4):625-36. PubMed ID: 17517961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]